Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Bioniche Life Sciences, a research-based, technology-driven Canadian biopharmaceutical company, has received an investment of $750,000 from Federal Economic Development Agency for Southern Ontario (FedDev Ontario).
Subscribe to our email newsletter
Bioniche’s research activities are focused mainly on small-scale, bench-top experiments. In order to scale-up the associated processes, a facility is required that houses pilot-scale fermentation equipment and downstream processing. The FedDev Ontario funding will provide such a facility.
Bioniche Life Sciences said that the investment is expected to support the development of a pilot-scale fermentation facility as part of the company’s Animal Health and Food Safety Vaccine Manufacturing Centre, currently under construction at the Belleville facility.
Daryl Kramp, MP for Prince Edward Hastings, said: “This investment will help stimulate the local economy as we recover from the economic recession. The pilot-scale fermentation facility will allow the development of advanced technologies for global markets and create employment in the advanced manufacturing sector in Southern Ontario.”
Graeme McRae, chairman, president and CEO of Bioniche Life Sciences, said: “The pilot-scale fermentation facility will be a critical add-on to our new state-of-the-art Vaccine Manufacturing Centre in Belleville. As successful animal health or food safety vaccine candidates are identified and evaluated, they will be brought into this new facility for development, scale-up and preparation for commercial-scale manufacturing.”